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As a follow up to the initial 1998 intercomparison study, a second study was initiated in 2001 as part of the ongoing 
evaluation of the capabilities of various ultra-sensitive methods to analyze 239Pu in urine samples. The initial study1 was 
sponsored by the Department of Energy, Office of International Health Programs to evaluate and validate new 
technologies that may supersede the existing fission tract analysis (FTA) method for the analysis of 239Pu in urine at the 
μBq/l level. The ultra-sensitive techniques evaluated in the second study included accelerator mass spectrometry (AMS) 
by LLNL, thermal ionization mass spectrometry (TIMS) by LANL and FTA by the University of Utah. Only the results 
for the mass spectrometric methods will be presented. For the second study, the testing levels were approximately 4, 9, 
29 and 56 μBq of 239Pu per liter of synthetic urine. Each test sample also contained 240Pu at a 240Pu/239Pu atom ratio of 
~0.15 and natural uranium at a concentration of 50 μBq/ml. From the results of the two studies, it can be inferred that 
the best performance at the μBq level is more laboratory specific than method specific. The second study demonstrated 
that LANL-TIMS and LLNL-AMS had essentially the same quantification level for both isotopes. Study results for bias 




The initial 1998 intercomparison study,1 entitled 
"Intercomparison Study of Inductively Coupled Plasma 
Mass Spectrometry, Thermal Ionization Mass 
Spectrometry and Fission Track Analysis of μBq 
Quantities of 239Pu in Synthetic Urine" was sponsored 
by the Department of Energy, Office of International 
Health Programs (EH-63). The purpose of the study 
was: (1) to independently evaluate the capability of the 
fission track analysis (FTA) methodology used by the 
Brookhaven National Laboratory to measure the 239Pu 
content in urine specimens collected from the Marshall 
Islanders and (2) to explore the potential capability of 
other ultra-sensitive methods for the measurement of 
μBq quantities of 239Pu in urine. The goal of the project 
was to evaluate the state-of-the-art fission track and 
mass-spectrometric methods in terms of accuracy and 
precision for 239Pu in synthetic urine within a 
concentration range between 4 to 60 μBq/sample. The 
results of the first study indicated that mass 
spectrometric techniques, used with chemical isolation 
of the plutonium from the urine specimen, were capable 
of detecting μBq quantities of 239Pu with a level of 
accuracy and precision that matched or exceeded those 
found for FTA. Details of the study, including 
experimental design, synopses of analytical methods 
and a summary of the test results for bias, precision, and 
detection capabilities (minimum detectable activity – 
MDA), have been presented at several national and 
international conferences including the Bioassay, 
Analytical and Environmental Radiochemistry      
Conference (1997) and the MARC IV Conference      
(1998). 
    
                                            
From the LANL meeting, three laboratories and the 
Department of Energy, Office of International Health 
Programs (EH-63) agreed to participant and/or fund the 
study. The laboratories included: Los Alamos National 
Laboratory; Health and Ecological Assessment Division 
of the Lawrence Livermore National Laboratory and the 
University of Utah. The study was initiated in 2001 and 
completed in 2002. This document provides a summary 
of the results obtained for the mass spectrometric 
capabilities of the Los Alamos National Laboratory 
using thermal ionization mass spectrometry and the 
Lawrence Livermore National Laboratory using 
accelerator mass spectrometry. In September of 1999, a meeting was held at the 
Los Alamos National Laboratory (LANL) to discuss the  
 
implementation of a second intercomparison study. 
Interested participants of the first study and some 
attendees of the NIST sponsored "1999 Workshop on 
Standards, Intercomparisons and Performance 
Evaluations for Low-Level and Environmental 
Radionuclide Mass Spectrometry and Atom Counting" 
attended the meeting. The meeting ended with a 
commitment of three laboratories and one support 
organization to fund the second study. The second study 
included a few additional testing elements, compared to 
the first study, to further determine instrument 
resolution and detection capabilities as well as the 
robustness of the chemical separation methods used to 
eliminate any inherent natural uranium that may result 
in possible interferences with the method of 239Pu 
detection. These included the addition of 240Pu to the 
spiked samples at a world-wide fallout 240Pu/239Pu atom 
ratio of ~0.15 and the inclusion of natural uranium at a 
level of 0.05 Bq/sample to all samples including the 
blanks. This level of natural uranium was chosen to be 
similar with the background urine levels in the vicinity 
of LANL. 
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Experimental 
The experimental design of the study was 
considered to be very realistic in terms of mimicking the 
typical isotopic 240Pu to 239Pu atom ratio for fallout, 
natural uranium interference level observed in 
background (non-exposed) populations and the 239Pu 
excretion levels in urine by certain study groups. The 
intercomparison study involved the analysis of five 
replicates 239Pu (plus 240Pu at a constant 240Pu: 239Pu ratio 
and natural uranium) in synthetic urine samples at five 
concentration levels ranging from zero (blank samples) 
to ~56 μBq/sample. The laboratories were to analyze 
each sample according to their standard method 
protocol and report each measurement value along with 
its associated measurement uncertainty (propagated 
combined standard uncertainty). 
Approach 
In order to effectively minimize potential Pu 
contamination from chemical reagents and working 
environment, high purity reagents were used and the 
entire sample preparation was conducted in a Class-
100 low-level radioactivity clean room facility at NIST. 
Synthetic urine matrix 
The synthetic urine sample blank material was 
prepared according to the recipe used in the first 
intercomparison study (Table 1) and by the Department 
of Energy in their DOE Laboratory Accreditation 
Program administered by the DOE Radiological and 
Environmental Sciences Laboratory. To minimize Pu 
contamination, ACS certified chemicals and distilled 
H2O were used for the sample matrix preparation. 
Chemicals for making up the 216kg of synthetic 
urine were weighed accurately into separate clean 
PYREX beakers and completely dissolved in 1N HNO3 
with gentle stirring and heating. Each of the resulting 
solutions was passed through a glass fiber filter (0.2 μm 
pore size) before transferring into a clean 225-liter 
polypropylene container. Following the addition of 22.2 
g of l0mg/ml cesium carrier solution into the container, 
the mixture was diluted gravimetrically up to 216kg 
with 1N HNO3 made from concentrated HNO3 and 
distilled H2O. The synthetic urine matrix was then 
vigorously mixed and allowed to equilibrate at room 
temperature for 4 days. The matrix solution was 
inspected periodically and no precipitation was observed 
during the equilibrium period. The blank urine matrix 
solution was then pumped into 205 pre-cleaned and pre-
weighed 1-liter size polypropylene bottles using a 
peristaltic pump. The filled bottles were weighed again 
to determine the mass of the matrix solution in each 
bottle. The prepared blank synthetic urine matrix had a 
density of 1.06g/ml and contained ~1 μ/g stable cesium 
and 1N HNO3. 
Plutonium spiking solutions 
The dilution and verification scheme for the  
preparation of the test samples appears in Fig. 1. The 
scheme was designed to prepare four test levels 
containing 239Pu (plus 240Pu at a constant 240Pu: 239Pu ratio 
and natural uranium at constant level) at approximately 
3.6, 9, 29 and 56 μBq per one-liter sample. In addition, 
the blank synthetic urine samples contained uranium at 
a final concentration of 0.05 Bq/sample. The Pu spiking 
solutions were prepared from NIST primary standard 
reference materials, SRM-4330B (239Pu) and SRM-
4338A (240Pu). The standard solution used for the U 
addition contained 5 Bq/ml of natural U and was 
prepared by diluting the NIST natural U (SRM-4321C) 
with 1N high purity HNO3. The entire sample spiking 
and gravimetric dilution process for the individual 
synthetic urine samples was experimentally verified by 
alpha-spectrometry and gamma-spectrometry.2 As 
shown in Fig. 1, Master-1 solution was prepared by 
gravimetric dilution of the 239Pu and 240Pu primary 
standards with 3N high purity HNO3 containing 10 μ/g 
stable Cs. The amounts of the 239Pu and 240Pu added 
were managed to yield an atom ratio of 240Pu/ 239Pu to 
be ~0.15.  The 134Cs tracer was also added to the 
Master-1 solution at this step for the verification of the 
subsequent gravimetric dilutions. High acid 
concentration and stable Cs carrier were used to prevent 
Pu and l34Cs from plating out of the solution. 
Individual sample spiking  
The prepared intercomparison samples were spiked 
individually with 0.06-0.15 g of the Master-L3 and -H3 
solutions depending on the activity levels targeted.  
Within each test level, the spike additions were carefully 
controlled to minimize sample-to-sample activity 
variation.  Following a careful mixing, the spiked 
samples were stored room temperature prior to the 
verification measurement.   
Addition of natural uranium and mask of level 
signatures 
Upon completion of the verification measurements, 
natural uranium and additional amounts of 134Cs and  137 Cs 
tracers were added to each sample, including blank samples.  
The natural U content of each sample was elevated to ~0.05 
Bq, a level typically found in the urine of non-affected 
populations in the vicinity of Los Alamos, NM.  The 
standard solution used for U addition contained 5Bq/ml of 
natural U and was prepared by diluting the NIST natural 
lU (SRM-4321C) with IN high purity HN3.  About 10 
μl of the diluted U standard solution was added to each 
urine sample using a micro volume pipettor. Tracing 
gravimetric dilutions with l34Cs and 137Cs resulted in each 
intercomparison sample bearing a distinctive Pu level-
signature that can be revealed by gamma-counting of its 
134Cs or l37Cs activities. Such level-signatures need to be 
erased prior to sample distribution. Similar to the method 
used for natural U addition, the level-signatures for the 
blank and the intercomparison samples were masked 
with appropriate amounts of l34Cs and 137Cs. 
Dilution verification 
To confirm gravimetric dilutions and ensure 
traceability of the intercomparison samples to the 
primary national standards, verification measurements 
were carried out in concert with the preparation 
  
processes to establish the traceability link between the 
activities of 239Pu and 240Pu in the intercomparison 
samples and their primary standards. As shown in Fig. 
1, two sets of check (CK) samples, 3 for each set, were 
taken at each step of the dilutions. The CK samples 
established an unbroken chain of comparison between 
the experimentally and the gravimetrically determined 
dilution factors. Two sets of CK samples were 
prepared to verify the dilution factors, DF1PU239 and 
DF1PU240 (from Pu SRMs to Master-1 solution), by 
alpha-spectrometry. The dilution factors, DFL2 and 
DFH2 (from Master-1 solution to Master-L2 and -H2 
solutions) were determined by gamma-spectrometric 
analysis of l34Cs. The same gamma-spectrometric 
analyses were performed for the determination of the 
dilution factors, DFL3 and DFH3 (from Master-L2 to 
Master-L3 and from Master-H2 to Master-H3). 
However, the l37Cs added at the later stage of the 
dilutions was measured to verify the dilution factors of 
DFL3 and DFH3. All of the CK samples spiked with 
134Cs and 137Cs were counted individually on a well-
type NaI detector and their gross gamma-activities 
normalized to the added spiking solution were 
examined for consistency. 
Analyte concentration uncertainties in test samples 
Table 2 summarizes the relative uncertainty 
components and the estimated relative combined 
standard uncertainties of 239Pu and 240Pu activities in 
the prepared intercomparison samples. The relative 
combined standard uncertainties are derived as the root-
sum-of-squares of the individual relative uncertainty 
components. 
Analytical methods of participating laboratories using 
mass spectrometry 
Table 3 summarizes the major analytical steps, test 
source preparation and instrument setup used by each 
laboratory to process the test samples. The reader is 
advised to directly contact the participating laboratories 
for additional chemical separations, test source mounting 
and measurement details. 
Results 
Outlier tests 
Statistical analyses were performed on the reported data 
using Box and Whisker plots and Normal Probability 
plots to detect potential outlier results at the 95% 
confidence level. The Box and Whisker plots revealed 
more potential outliers compared to the Normal 
Probability plots. The results of the outlier tests 
revealed that LANL had no outliers for the 239Pu results  
and two possible outliers (test levels 2 and 4) for the 
240Pu results. For LLNL, only one potential outlier in the 
second test level of the 239Pu results and no potential 
outliers in the 240Pu results were indicated. Although a 
very limited number of outliers were observed by the 
statistical tests, the outliers were not discounted or 
censored when calculating the mean bias, precision or 
detection limit parameters reported in this document. 
Mean, standard deviation and bias 
For each testing level, the mean and the standard 
deviation of the reported values, the difference 
between the laboratory's reported value and the NIST's 
value, and the mean difference (bias) from the NIST 
values were determined. For this study, the relative 
standard deviation of the five results per test level 
(including blanks) was used as an indicator for method 
precision. The percent relative standard deviation was 
expressed in terms of the percent of the mean test level 
value (coefficient of variation). In addition, for each 
test level data set, the standard deviation of the 
difference from the NIST value was calculated to 
determine precision as defined in the guidance provided 
in ANSI N13.30.3 Tables 4 and 5 summarize the mean 
value and standard deviation of the five replicates for 
each test level as well as the mean difference from 
NIST for each 239Pu test level in terms (μBq per sample. 
Table 6 provides the same summary for the 240Pu 
sample results. The mean blank results were not 
subtracted from the submitted measurement values for 
the spiked testing ranges. 
The information and data provided by each 
participant was used to estimated the typical combined 
standard uncertainty for a measurement for a given test 
level. Tables 7 summarize the 239Pu and 240Pu estimated 
combined standard uncertainties for each test level by 
participant.  
Report of traceability for 239Pu analyses 
Tables 4 and 5 summarize each laboratory's mean bias 
for each test level, the determination of measurement 
traceability at each test level as the per ANSI N42.224 
testing criterion and the determination of radiobioassay 
acceptable performance as per ANSI N13.30. 
ANSI N42.22 defines the traceability limit to NIST for 
performance testing as:  
 
⏐VN − VL⏐≤3 SQRT(δN2 + δL2)                                    
 
where VN is the NIST value, VL is the laboratory 
value, δN is the combined standard uncertainty of VN 
and δL is the combined standard uncertainty of VL. For 
this study, the mean value and estimated combined 
standard uncertainty for each test level were used to 
evaluate conformance with the ANSI N42.22 
performance criterion. 
The acceptable ANSI 13.30 criteria for bias 
(average difference from the known testing value) and 
the standard deviation of the bias for a test level are 
25 to +50%, and ±40% (1s), respectively. 
Detection limits (MSAs) 
The 239Pu and 240Pu data from each laboratory were 
statistically evaluated, in comparison to the NIST values, 
using a linear regression model. Figures 2 and 3 
graphically illustrate the relationship of the LANL-
TIMS and LLNL-AMS 239Pu data with respect to the 
NIST values and the 90% prediction interval (two sided) 
for the fitted linear function. From this statistical analysis, 
an estimate of the decision level and detection limit for 
each mass spectrometric method was calculated based on 
the work of HUBAUX and Vos.5 Table 8 summarizes the 
  
detection limit estimate based on HUBAUX and Vos method 
as well as the classical method of CURRIE.6 The estimated 
detection limits are based on a kα and kβ=1.645. 
Discussion 
The observed performance of LANL and LLNL, as 
found in Tables 4 and 5 for 239Pu and Table 6 for 240Pu has 
been summarized below. 
239Pu method bias 
When compared to the ANSI N13.30 testing 
criterion, both laboratories had an acceptable mean test 
level bias (difference from NIST) for the highest two 
testing levels (29 and 56 μBq/sample). It should be 
noted that, as a result of the measurement precision and 
the limited number of samples per test level, the 
calculated mean bias for both laboratories would not be 
statistically different from zero at the 5% significance 
level. Both the LLNL AMS and LANL TIMS had a 
calculated mean bias for the highest two test levels that 
was less than 5%, which indicates that their chemical 
yield monitors were accurately prepared and maintained 
with respect to their relationship to NIST standards. 
For the lowest two test levels (3.6 and 8.9 μBq/sample), 
both LLNL AMS and LANL TIMS had a calculated 
negative mean bias between -8.2 and -12.8%. The 
reason for the "apparent" negative bias is not readily 
apparent since both labs had no significant biases (mean 
of blank value was not statistically different that zero at 
the 5% significance level) with respect to the 
measurement of the analytical blanks incorporated in the 
study. 
240Pu method bias 
Table 6 summarizes the measured mean 240Pu test 
level bias for both laboratories. Both laboratories had 
greater 240Pu biases at all test levels compared to the 
239Pu biases measured at similar test levels. This was 
expected for these 240Pu concentrations since the number of 
240Pu atoms was about seven times lower than the 
number of 239Pu atoms in the test samples. The LLNL 
AMS method had the least bias for analyzing 240Pu at all 
test levels. The measured bias for the LLNL measurement 
ranged from 0.69% to 14.6%, with the least bias being 
associated with the highest test level. For the LANL 
TIMS measurements, the mean bias per level varied from 
11.7 at the highest test level to 83.1 at the lowest test 
level. A negative bias of -24.9% was noted for the 5.2 
μBq/sample test level. 
239Pu precision 
The calculated random uncertainty components 
(coefficient of variation of the five measurement with 
respect to the mean value) for each test level and 
laboratory have been summarized in Table 7 under the 
random and replicate column. For both LANL and 
LLNL, the calculated random uncertainty component 
per test level decreased with increasing 239Pu 
concentration. This trend is consistent with expectations. 
Both LANL TIMS and LLNL AMS had excellent 
precision (<7%) at the two highest test levels. However, 
compared to LLNL AMS, the LANL TIMS method had a 
smaller coefficient of variation (1s) for the two highest 
testing levels (3.8% and 4.4%). However, at the two 
lowest test levels of 4 and 9 μBq/sample, LLNL's 
precision was found to be 31.3 and 11.4% (1s), 
respectively, or almost a factor of two better than 
LANL's precision at these test levels. At the lowest test 
level of 4 μBq, the method precision of LANL TIMS 
and LLNL AMS was consistent with expectations based 
on an estimated detection limit of 6 μBq/sample for both 
participants. 
240Pu precision 
The mean 240Pu precision values for each test levels, 
as measured by the coefficient of variation of the data 
per test level, have been summarized in Tables 6 and 7. 
Overall for the spiked test levels, the precision for the 
240Pu measurements was at least a factor of two more 
imprecise (and up to a factor of 8.2 more imprecise) than 
the precision for the 239Pu measurements. LANL TIMS had 
the best 240Pu precision for two highest test levels (16 and 
32 μBq/sample) whereas LLNL AMS achieved better 
method precision for lowest test levels (2.1 and 5.2 
(μBq/sample). Both the LLNL AMS and the LANL 
TIMS had similar coefficient of variation values for the 
blank analyses (~300 to 400%). 
ANSI performance for 239Pu measurements 
The 239Pu results from the laboratories were 
evaluated against ANSI N42.22 and ANSI N13.30 
performance criteria (Tables 4 and 5). Both LANL and 
LLNL demonstrated their ability to make traceable 
measurements, per ANSI N42.22, at all four test levels. 
Both laboratories had sufficiently low biases at all test 
levels to meet the ANSI criterion for traceability. 
Both laboratories passed the ANSI N13.30 performance 
criterion for 239Pu bias (-25% to +50%) by a very 
substantial margin. In addition, LLNL passed the ANSI 
N13.30 precision criterion of ±40% for all test levels. 
LANL passed the precision criterion at all levels except 
the lowest test level of 3.57 μBq/sample. LANL's method 
precision at this test level was 55.5% or slightly greater 
than the required limit of ±40%. 
Detection limits (MDAs) 
Both laboratories had excellent detection 
capabilities for 239Pu in the synthetic urine samples. 
From this statistical analysis of the data, an estimate of 
the detection limit for each mass spectrometric method 
was calculated based on the work of HUBAUX and 
Vos5 and CURRIE6 (Table 8). The detection limit 
estimated by the HUBAUX and Vos approach uses the 
data for all test levels plus the blank results. Based on 
this approach, a detection limit of ~6 μBq/sample was 
estimated for both LANL and LLNL. Using the 
approach of CURRIE with blank data only, a detection 
limit of 0.82 and 5.2 (μBq/sample was estimated for 
LLNL and LANL, respectively. In the first 
intercomparison study, the estimated detection limit for 
LANL using an extrapolation and ANSI N13.30 
approach was 0.6 μBq/200 g sample. 
  
For 240Pu, the estimated detection limit based on the 
HUBAUX and VOS approach was between 15-20 
μBq/sample for both laboratories. LLNL had a much 
lower detection limit (2.1 μBq/sample) than LANL (24 
(μBq/sample) when estimated using the currie approach. 
Conclusions 
This intercomparison study has shown that 
laboratories have developed state-of-the-art analytical 
methods for the determination of μBq levels of 239Pu in 
urine specimens. However, this study is considered 
only a temporal snapshot of a laboratory's capability and 
does not reflect a laboratory's future capability or its 
routine operational performance for any given project 
or program. In general, based on the results of the first 
and second intercomparison studies that included four 
different methods, the performance in such studies 
may not be indicative of the method employed but the 
performance may be more reflective of the laboratory's 
proficiency, routine operational experience and the 
depth of technical experience for various study designs. 
This second intercomparison study was somewhat 
different from the first study in terms of laboratory 
participants, study design and data assessment. Some 
of the data assessment methods used in the first study 
were retained in the second study. However, many new 
assessment tools were used in the second study that 
provided an alternative statistical approach for the 
measurement of outliers, bias, precision and 
quantification capability. As such, results of the two 
studies cannot be directly compared but certain 
inferences can be made. The approach to estimate and 
compare method detection capabilities (MDA) were 
quite different and, as a result, the stated method 
detection values estimated in the first study may be, for 
some laboratories, lower than those estimated in this 
study. It is believed that these study design and data 
assessment enhancements of the second study provided 
a more realistic study and laboratory performance 
evaluations. 
The performance of both the LANL TIMS and 
LLNL AMS, in terms of 239Pu bias and precision, was in 
compliance with the ANSI N13.30 performance 
requirements for all test levels except for LANL at the 
lowest test level. For the two test levels above 29 
μBq/sample, the measured bias (as per ANSI N13.30) 
for both laboratories was less than 5%. The most severe 
bias for 239Pu, of only ~13%, was noted for the 9 
μBq/sample test level. The measured 240Pu bias varied 
from <1% at the highest test level (32 μBq/sample) to 
83% at the lowest test level (2.1 μBq/sample). For both 
laboratories, the measured method precision for either 
plutonium isotope decreased with increasing test level 
concentration, with the best 239Pu precision (3.8%) noted 
for LANL at the highest test level (29 μBq/sample). The 
excellent 239Pu precision indicates that both laboratories 
had a good blank control process and a knowledge of 
the parameters contributing to the uncertainty of the 
method. For both laboratories, the 240Pu precision for all 
test levels was at least a factor 2 worse, but up to 8 
times worse, than the measured 239Pu precision. The 
LLNL AMS method performed at least as well as the 
LANL TIMS method in terms of precision for both 
plutonium isotopes, and for accuracy (bias) for 239Pu. 
The AMS method was found to have a smaller 240Pu 
bias when compared to the TIMS method. 
For both laboratories, the detection capability 
(MDA) based on a regression method was estimated to 
be 5 to 6 (μBq/sample for 239Pu and ~20 μBq/sample for 
240Pu. In comparison to the regression method to 
estimate the MDA values, LLNL had much lower 
MDA values for both isotopes using the Currie method 
to estimate the MDAs.  These detection limits appear 
to be the best that can be attained for 239Pu and 239Pu 
radiobioassay urine measurements. The LANL TIMS 
239Pu MDA of 5 to 6 μBq estimated for this study was 
about an order of magnitude greater than that estimated 
for the first study. However, the estimated 239Pu MDA 
in the first study was estimated by a different statistical 
analysis. 
For detectable concentrations, the performance 
(accuracy and precision) of mass spectrometric 
methods for the radiobioassay of urine samples is 
excellent and equivalent to radioanalytical method 
using radioactive decay emission analysis (alpha-
spectrometry). However, the detection capability of the 
mass spectrometric methods is several orders of 
magnitude better than that of alpha-spectrometry. 
This work was performed under the auspices of the 
U.S. Department of Energy by the University of 
California, Lawrence Livermore National Laboratory 
under Contract No. W-7405-Eng-48. 
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